Eagle Pharma Targets Hiked At Piper Jaffray On 'Room For Value Creation'
July 29, 2015 at 10:19 AM EDT
In a report published Wednesday, Piper Jaffray analyst David Amsellem maintained an Overweight rating on Eagle Pharmaceuticals Inc ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.